News and Announcements

Chemomab Announces CM-101 Phase 2 SPRING Trial Results

Three Recent Announcements from: Pliant, NGM, and Chemomab PSC Partners is encouraged by the initial positive data from the CM-101 Phase...

Jul 29, 2024

Positive Update on Pliant’s INTEGRIS-PSC Phase 2a Trial

On July 15, 2024, Pliant Therapeutics announced positive results from their Phase 2a INTEGRIS-PSC trial for bexotegrast in treatment of...

Jul 21, 2024

New Article on an Adaptive Treatment Strategy for Use of Vancomycin in PSC

The repurposing of approved medications with potential new efficacy in rare diseases is challenging, as these medications are unlikely to...

Jun 24, 2024

Expanded Inclusion Criteria for Mirum’s VISTAS PSC Study for Pruritus Treatment

The following is a message from Mirum Pharmaceuticals regarding their VISTAS study for volixibat, a possible new treatment for...

Jun 21, 2024

A New Era for the PSC Partners Registry Community

Dear Registry Participants (Current and Future), This year is the 10th anniversary of the PSC Partners Patient Registry, a perfect time for renewal, for the upgrade you can experience when you log into the Registry. What you will experience is only the tip of the iceberg . The Registry is fulfilling a PSC Partners dream transformed into the tangible goal of facilitating and speeding up research towards PSC treatments and a cure. This progress could only take place thanks

Mar 17, 2024